Treatment of childhood migraine attacks with oral zolmitriptan and ibuprofen

被引:65
作者
Evers, S.
Rahmann, A.
Kraemer, C.
Kurlemann, G.
Debus, O.
Husstedt, I. W.
Frese, A.
机构
[1] Univ Munster, Dept Neurol, Munster, Germany
[2] Univ Munster, Dept Neuropaediat, Munster, Germany
关键词
D O I
10.1212/01.wnl.0000231138.18629.d5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The authors conducted a double-blind, placebo-controlled, crossover study to investigate the efficacy of oral zolmitriptan in the treatment of migraine in children and adolescents. Patients ( n = 32) received placebo, zolmitriptan 2.5 mg, and ibuprofen 200 to 400 mg to treat three consecutive migraine attacks. Pain relief rates after 2 hours were 28% for placebo, 62% for zolmitriptan, and 69% for ibuprofen ( p < 0.05). Both drugs are well tolerated with only mild side effects.
引用
收藏
页码:497 / 499
页数:3
相关论文
共 10 条
[1]
Nasal sumatriptan is effective in treatment of migraine attacks in children -: A randomized trial [J].
Ahonen, K ;
Hämäläinen, ML ;
Rantala, H ;
Hoppu, K .
NEUROLOGY, 2004, 62 (06) :883-887
[2]
Ibuprofen or acetaminophen for the acute treatment of migraine in children: A double-blind, randomized, placebo-controlled, crossover study [J].
Hamalainen, ML ;
Hoppu, K ;
Valkeila, E ;
Santavuori, P .
NEUROLOGY, 1997, 48 (01) :103-107
[3]
Children's ibuprofen suspension for the acute treatment of pediatric migraine [J].
Lewis, DW ;
Kellstein, D ;
Dahl, G ;
Burke, B ;
Frank, LM ;
Toor, S ;
Northam, RS ;
White, LW ;
Lawson, L .
HEADACHE, 2002, 42 (08) :780-786
[4]
Linder SL, 2000, INT J CLIN PRACT, V54, P466
[5]
Migraine pathophysiology and its clinical implications [J].
Silberstein, SD .
CEPHALALGIA, 2004, 24 :2-7
[6]
Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine [J].
Solomon, GD ;
Cady, RK ;
Klapper, JA ;
Earl, NL ;
Saper, JR ;
Ramadan, NM .
NEUROLOGY, 1997, 49 (05) :1219-1225
[7]
Intranasal sumatriptan for the acute treatment of migraine in children [J].
Ueberall, MA ;
Wenzel, D .
NEUROLOGY, 1999, 52 (07) :1507-1510
[8]
Demographic and migraine characteristics of adolescents with migraine: Glaxo Wellcome clinical trials' database [J].
Winner, P ;
Rothner, AD ;
Putnam, DG ;
Asgharnejad, M .
HEADACHE, 2003, 43 (05) :451-457
[9]
Rizatriptan 5 mg for the acute treatment of migraine in adolescents: A randomized, double-blind, placebo-controlled study [J].
Winner, P ;
Lewis, D ;
Visser, WH ;
Jiang, KH ;
Ahrens, S ;
Evans, JK .
HEADACHE, 2002, 42 (01) :49-55
[10]
A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents [J].
Winner, P ;
Rothner, AD ;
Saper, J ;
Nett, R ;
Asgharnejad, M ;
Laurenza, A ;
Austin, R ;
Peykamian, M .
PEDIATRICS, 2000, 106 (05) :989-997